RespireRx Pharmaceuticals Inc (fka RSPI)

[haysaw]

Thanks for trying to explain. I guess it's somewhat of a gray area. I'm wondering if the unreleased trial data can be divulged to the potential acquirer (to more effectually estimate Cor's value), and at the same time, not release it to us because it is then intertwined in negotiations and part of insider info?

Maybe this is something that is done informally , meaning Cor gives the takeover candidate a glimpse of info from the ongoing study, but cannot officially or formally disclose the trial data, because it would violate disclosure laws. I think you may have alluded to that in one of your posts.